Dr. Willie J Levesque, PA-C, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 852 Prospect St, Plantsville, CT 06479 Phone: 617-594-9372 |
Ben C. Reilly, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 645 Main St, Plantsville, CT 06479 Phone: 860-579-4021 |
News Archive
Results of a study by investigators at St. Jude Children's Research Hospital provide strong evidence for why the drug imatinib (Gleevec), which has revolutionized the treatment of chronic myelogenous leukemia (CML), is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
There have been many studies showing the increased risk of mortality and morbidity associated with obesity. Obesity has been known to be associated with diseases such as heart disease, diabetes and even cancers.
Could weight loss surgery before knee replacement improve outcomes or even eliminate the need for joint replacement in severely overweight patients? A study by researchers at Hospital for Special Surgery aims to answer that question.
› Verified 9 days ago